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Abstract
15
We assessed in a piglet model the relationship between fecal ciprofloxacin concentrations and because it compromises their therapeutic use (6, 7). Colonic flora is the reservoir of many of 24 the Enterobacteriaceae species with clinical significance (2) which are exposed to antibiotic 25 residues during fluoroquinolone treatments (9). It has been shown that administration of 26 enrofloxacin, a fluoroquinolone used in animals, could promote the emergence of quinolone 27 resistant enterobacteria in fecal flora of pigs (12). We also found that administration of oral 28 ciprofloxacin is associated with the emergence of quinolone resistant strains of 29 Enterobacteriaceae in fecal flora from human volunteers (3). However, rates of emergence of 30 resistance were not significantly different although the volunteers were exposed to different 31 antibiotic dosages. Of note, detection of resistance was only qualitative in that study, i.e. Twenty-nine piglets from a single farm were included 4 weeks after birth. They were born 43 from sows that were treated at the time of parturition with 2 g oxytetracycline given 44 intramuscularly, but had not received directly any antimicrobials. Piglets were housed in 45 individual boxes for 21 days before the start of treatment (D1) and were randomly assigned to level at 0.05). All statistical analyses were performed using SAS 9.1 (SAS, Cary, NC).
67
Concentrations of ciprofloxacin increased with the dose administered and peaked at 84.8±57.9 68 versus 11.6±12.6 µg/g of feces at D5 in piglets treated with 15 and 1.5 mg/kg/day of 69 ciprofloxacin respectively (p<0.001) (Fig. 1A) . Fecal antibiotic activity was detectable to 70 some extent in all animals 2 days after cessation of treatment (D7) but no activity was (Fig. 1B) and percentages of ciprofloxacin resistant enterobacteria (Fig. 1C of AUC_CIP to obtain 50% of the maximal effect (Fig. 2) . 89 We showed a significant positive correlation between the AUC of fecal ciprofloxacin 
